Richard Anderson
Stock Analyst at Cantor Fitzgerald
(3.62)
# 813
Out of 5,152 analysts
205
Total ratings
60%
Success rate
2.86%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HPP Hudson Pacific Properties | Maintains: Overweight | $13 → $10 | $7.44 | +34.41% | 8 | Mar 2, 2026 | |
| HR Healthcare Realty Trust | Maintains: Overweight | $19 → $21 | $18.38 | +14.25% | 11 | Feb 17, 2026 | |
| CTRE CareTrust REIT | Maintains: Neutral | $37 → $42 | $39.50 | +6.33% | 5 | Feb 17, 2026 | |
| SBRA Sabra Health Care REIT | Maintains: Neutral | $20 → $21 | $20.06 | +4.71% | 7 | Feb 17, 2026 | |
| WELL Welltower | Maintains: Overweight | $204 → $230 | $204.00 | +12.75% | 8 | Feb 12, 2026 | |
| UDR UDR, Inc. | Maintains: Neutral | $37 → $42 | $37.65 | +11.55% | 6 | Feb 11, 2026 | |
| OHI Omega Healthcare Investors | Maintains: Overweight | $50 → $52 | $47.14 | +10.31% | 3 | Feb 10, 2026 | |
| MAA Mid-America Apartment Communities | Maintains: Neutral | $137 → $141 | $134.32 | +4.97% | 6 | Feb 9, 2026 | |
| ESS Essex Property Trust | Reiterates: Overweight | $300 | $257.50 | +16.50% | 10 | Feb 9, 2026 | |
| EQR Equity Residential | Maintains: Neutral | $61 → $64 | $63.01 | +1.57% | 7 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $105 → $108 | $108.39 | -0.36% | 6 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $179 → $186 | $178.92 | +3.96% | 3 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $93 | $85.26 | +9.08% | 10 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $37 | $32.52 | +13.78% | 5 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $75 | $63.91 | +17.35% | 4 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $45 | $36.94 | +21.82% | 3 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $64 | $61.43 | +4.18% | 7 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $210 | $191.86 | +9.45% | 8 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $79 | $55.36 | +42.70% | 8 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $10.18 | +27.70% | 4 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $79 → $52 | $51.95 | +0.10% | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $37 | $29.70 | +24.58% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $15 | $14.83 | +1.15% | 5 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $14 | $12.87 | +8.82% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $37 | $38.97 | -5.06% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $17 | $15.51 | +9.61% | 6 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $108 | $97.98 | +10.23% | 2 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $12 | $11.26 | +6.62% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $12 | $12.92 | -7.12% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $64 | $64.77 | -1.19% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $20.89 | +0.53% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $84.36 | +6.69% | 5 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $38 | $38.17 | -0.45% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $19 | $19.88 | -4.43% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $51 | $49.33 | +3.39% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $34.37 | +1.83% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $17.38 | +15.07% | 6 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $62 | $61.87 | +0.22% | 2 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $18.99 | +10.58% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $14 | $12.43 | +12.68% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.34 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.13 | - | 2 | Jul 10, 2017 |
Hudson Pacific Properties
Mar 2, 2026
Maintains: Overweight
Price Target: $13 → $10
Current: $7.44
Upside: +34.41%
Healthcare Realty Trust
Feb 17, 2026
Maintains: Overweight
Price Target: $19 → $21
Current: $18.38
Upside: +14.25%
CareTrust REIT
Feb 17, 2026
Maintains: Neutral
Price Target: $37 → $42
Current: $39.50
Upside: +6.33%
Sabra Health Care REIT
Feb 17, 2026
Maintains: Neutral
Price Target: $20 → $21
Current: $20.06
Upside: +4.71%
Welltower
Feb 12, 2026
Maintains: Overweight
Price Target: $204 → $230
Current: $204.00
Upside: +12.75%
UDR, Inc.
Feb 11, 2026
Maintains: Neutral
Price Target: $37 → $42
Current: $37.65
Upside: +11.55%
Omega Healthcare Investors
Feb 10, 2026
Maintains: Overweight
Price Target: $50 → $52
Current: $47.14
Upside: +10.31%
Mid-America Apartment Communities
Feb 9, 2026
Maintains: Neutral
Price Target: $137 → $141
Current: $134.32
Upside: +4.97%
Essex Property Trust
Feb 9, 2026
Reiterates: Overweight
Price Target: $300
Current: $257.50
Upside: +16.50%
Equity Residential
Feb 9, 2026
Maintains: Neutral
Price Target: $61 → $64
Current: $63.01
Upside: +1.57%
Feb 9, 2026
Maintains: Neutral
Price Target: $105 → $108
Current: $108.39
Upside: -0.36%
Feb 9, 2026
Maintains: Neutral
Price Target: $179 → $186
Current: $178.92
Upside: +3.96%
Feb 9, 2026
Reiterates: Overweight
Price Target: $93
Current: $85.26
Upside: +9.08%
Feb 9, 2026
Maintains: Overweight
Price Target: $33 → $37
Current: $32.52
Upside: +13.78%
Feb 6, 2026
Maintains: Overweight
Price Target: $67 → $75
Current: $63.91
Upside: +17.35%
Feb 6, 2026
Maintains: Overweight
Price Target: $50 → $45
Current: $36.94
Upside: +21.82%
Feb 6, 2026
Maintains: Neutral
Price Target: $58 → $64
Current: $61.43
Upside: +4.18%
Feb 6, 2026
Maintains: Overweight
Price Target: $200 → $210
Current: $191.86
Upside: +9.45%
Jan 29, 2026
Reiterates: Overweight
Price Target: $79
Current: $55.36
Upside: +42.70%
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $13
Current: $10.18
Upside: +27.70%
Oct 30, 2025
Maintains: Neutral
Price Target: $79 → $52
Current: $51.95
Upside: +0.10%
Oct 1, 2025
Initiates: Overweight
Price Target: $37
Current: $29.70
Upside: +24.58%
Oct 1, 2025
Initiates: Neutral
Price Target: $15
Current: $14.83
Upside: +1.15%
Oct 1, 2025
Initiates: Overweight
Price Target: $14
Current: $12.87
Upside: +8.82%
Oct 1, 2025
Initiates: Neutral
Price Target: $37
Current: $38.97
Upside: -5.06%
Oct 1, 2025
Initiates: Neutral
Price Target: $17
Current: $15.51
Upside: +9.61%
Oct 1, 2025
Initiates: Overweight
Price Target: $108
Current: $97.98
Upside: +10.23%
Oct 1, 2025
Initiates: Neutral
Price Target: $12
Current: $11.26
Upside: +6.62%
Oct 1, 2025
Initiates: Neutral
Price Target: $12
Current: $12.92
Upside: -7.12%
Oct 1, 2025
Initiates: Neutral
Price Target: $64
Current: $64.77
Upside: -1.19%
Oct 1, 2025
Initiates: Overweight
Price Target: $21
Current: $20.89
Upside: +0.53%
Oct 1, 2025
Initiates: Overweight
Price Target: $90
Current: $84.36
Upside: +6.69%
Oct 1, 2025
Initiates: Neutral
Price Target: $38
Current: $38.17
Upside: -0.45%
Oct 1, 2025
Initiates: Neutral
Price Target: $19
Current: $19.88
Upside: -4.43%
Oct 1, 2025
Initiates: Neutral
Price Target: $51
Current: $49.33
Upside: +3.39%
Oct 1, 2025
Initiates: Overweight
Price Target: $35
Current: $34.37
Upside: +1.83%
Oct 1, 2025
Initiates: Neutral
Price Target: $20
Current: $17.38
Upside: +15.07%
Oct 1, 2025
Initiates: Neutral
Price Target: $62
Current: $61.87
Upside: +0.22%
Oct 1, 2025
Initiates: Overweight
Price Target: $21
Current: $18.99
Upside: +10.58%
Oct 1, 2025
Initiates: Overweight
Price Target: $14
Current: $12.43
Upside: +12.68%
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $4.34
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $3.13
Upside: -